Abiko et al. (2015) demonstrated that IFN-γ, which induced GBP1 expression, promoted PD-L1 expression on ovarian cancer cells and mouse models. In addition, other immune checkpoint pathways such as CTLA-4 were reinforced by IFN-γ (Wang et al., 2001). This evidence concerns the gene GBP1 and ovarian carcinoma.